First National Bank of Omaha’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

First National Bank of Omaha’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-38,462	Closed	-$4.45M	–	326
2023 Q3	$4.45M	Sell	38,462 -6,418	-14%	-$690K	0.29%	110
2023 Q2	$4.62M	Sell	44,880 -1,771	-4%	-$187K	0.27%	120
2023 Q1	$5.09M	Sell	46,651 -55,282	-54%	-$6.11M	0.31%	110
2022 Q4	$11.6M	Sell	101,933 -2,533	-2%	-$210K	0.72%	34
2022 Q3	$6.47M	Buy	104,466 +8,525	+9%	+$596K	0.42%	76
2022 Q2	$7.65M	Buy	95,941 +14,625	+18%	+$1.38M	0.46%	66
2022 Q1	$8.56M	Buy	81,316 +12,761	+19%	+$1.24M	0.44%	72
2021 Q4	$7.39M	Sell	68,555 -3,234	-5%	-$353K	0.35%	86
2021 Q3	$7.86M	Sell	71,789 -3,636	-5%	-$377K	0.4%	74
2021 Q2	$6.94M	Hold	75,425	–	–	0.36%	91
2021 Q1	$6.94M	Buy	75,425 +524	+0.7%	+$44.2K	0.36%	91
2020 Q4	$5.48M	Sell	74,901 -19,989	-21%	-$1.49M	0.3%	111
2020 Q3	$7.37M	Buy	94,890 +2,534	+3%	+$174K	0.46%	71
2020 Q2	$5.13M	Buy	+92,356	New	+$3.95M	0.34%	96

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

First National Bank of Omaha's HZNP Position: Q4 2023 in Review

First National Bank of Omaha sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 38,462 shares — an estimated $4.45M sold.

First National Bank of Omaha first reported a position in HZNP in Q2 2020 and held it in 14 quarters. The position peaked at $11.6M in Q4 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

First National Bank of Omaha reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
First National Bank of Omaha sold 38,462 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $4.45M.
First National Bank of Omaha first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2020 and held it in 14 quarters.
First National Bank of Omaha's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $11.6M in Q4 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on First National Bank of Omaha's 13F filing for Q4 2023, filed 13 Feb 2024.